Try a new search

Format these results:

Searched for:



Total Results:


Effects of Pharmacological Agents on Human Amniotic Fluid Derived Stem Cells in Culture

Dziadosz, Margaret; Chan, Michael; Basch, Ross; Young, Bruce K
Amniotic fluid contains multipotent cells and could be a source of stem cells for clinical use. Amniotic fluid cells (AFC) are made up of a heterogeneous population of fetal cells that can be retrieved during pregnancy without ethical concernsas it is a standard clinical procedure-. Studies of proliferation, multipotent marker expression, differentiation, and gene expression were performed after culturing with dexamethasone, valproic acid and magnesium sulfate. There were correlations between known drug effects on the human fetus and changes seen in human AFC in culture, as well as previously undescribed observations in neural and chondrogenic inducibility. Gene expression profiles confirmed these observations. AFC culture may provide a novel method to evaluate pharmacological agents before clinical use in pregnancy.
PMID: 27451014
ISSN: 1557-8534
CID: 2191362

Human amniotic fluid: a source of stem cells for possible therapeutic use

Dziadosz, Margaret; Basch, Ross S; Young, Bruce K
Stem cells are undifferentiated cells with the capacity for differentiation. Amniotic fluid cells (AFC) have only recently emerged as a possible source of stem cells for clinical purposes. There are no ethical or sampling constraints using amniocentesis as a standard clinical procedure for obtaining an abundant supply of AFC. AFC of human origin proliferate rapidly and are multipotent with the potential for expansion in vitro to multiple cell lines. Tissue engineering technologies using AFC are being explored. AFC may be of clinical benefit for fetal therapies, degenerative disease and regenerative medicine applications. We present a comprehensive review of the evolution of human amniotic fluid cells as a possible modality for therapeutic use.
PMID: 26767797
ISSN: 1097-6868
CID: 1912732

Heterogeneity of Stem Cells in Human Amniotic Fluid

Chen, Zhisheng; Chan, Michael K; Strelchenko, Nicholas; Wang, Fang; Liu, Li; Perle, Mary Ann; Basch, Ross S; Young, Bruce K
Amniotic fluid contains a mixture of cells with capacity to differentiate into all germ layers. These cells are present in large numbers in midtrimester samples obtained for cytogenetic diagnosis, and have been identified by stem cell surface markers and transcription factors. We studied cultured samples from patients who had both direct cultures and matched cultures obtained 2 weeks later from the cytogenetics laboratory as well as patients with cytogenetics material only. Samples were cryogenically frozen, thawed, expanded in culture with excellent viability. There was considerable individual variation unrelated to gestational age or telomere length. Phenotype for embryonic markers was assessed by flow cytometry and by quantitative polymerase chain reaction. The most consistently present stem cell markers in substantial amounts were CD90, SSEA-4, & TRA-1-60. Cells with CD90, SSEA-4 & TRA-1-60 double and triple labeled also could be identified and subcultured, confirming the heterogeneity of the amniotic fluid stem cell population
ISSN: 2325-9620
CID: 1908162

Clinical potential of human amniotic fluid stem cells

Martin, Monique M; Chan, Michael; Antoine, Clarel; Bar-El, Liron; Bornstein, Eran; Young, Bruce K
PMID: 38164020
ISSN: 1619-3997
CID: 5633102

Amniotic fluid embolism: a reappraisal

Young, Bruce K; Florine Magdelijns, Pascalle; Chervenak, Judith L; Chan, Michael
OBJECTIVES/OBJECTIVE:Using cases from our own experience and from the published literature on amniotic fluid embolism (AFE), we seek to improve on existing criteria for diagnosis and discern associated risk factors. Additionally, we propose a novel theory of pathophysiology. METHODS:This retrospective case review includes eight cases of AFE from two hospital systems and 21 from the published literature. All cases were evaluated using the modified criteria for research reporting of AFE by Clark et al. in Am J Obstet Gynecol, 2016;215:408-12 as well as our proposed criteria for diagnosis. Additional clinical and demographic characteristics potentially correlated with a risk of AFE were included and analyzed using descriptive analysis. RESULTS:fertilization. 6.5 % of cases were complicated by fetal death. Placenta previa occurred in 13.8 %. 86.2 % of women had cesarean sections of which 52.0 % had no acute maternal indication. CONCLUSIONS:Our criteria identify more patients with AFE than others with a low likelihood of false positives. Clinical and demographic associations in our review are consistent with those previously reported. A possible relationship between cesarean birth and risk of AFE was identified using our criteria. Additionally, we propose a new hypothesis of pathophysiology.
PMID: 38082418
ISSN: 1619-3997
CID: 5589142

Clinical potential of human amniotic fluid stem cells

Martin, Monique M; Chan, Michael; Antoine, Clarel; Bar-El, Liron; Bornstein, Eran; Young, Bruce K
OBJECTIVES/OBJECTIVE:To determine whether amniotic fluid derived stem cells maintain their stem cell characteristics (a) after processing by a licensed cell therapy center and (b) after the cells undergo simulated clinical application. METHODS:Amniotic fluid was collected by laparotomy - a small uterine incision was made at proposed site for delivery and a sterile catheter inserted to collect fluid into a sterile bag. After flow stopped the catheter was withdrawn, the cesarean completed and the collected fluid delivered to the cell therapy center for processing and cryostorage. A clinical setting was simulated where amniotic fluid cells received from cell therapy center were thawed at room temperature for a maximum of 3 h and passed through a clinical cell delivery device to monitor cell viability. The cells were examined for viability, stability, growth, differentiation, and markers of stemness. RESULTS:Amniotic fluid stem cells processed from a clinical cell therapy center behave similarly to amniotic fluid stem cells processed in a research laboratory with respects to viability, stability, growth, differentiation and maintain markers of stemness. There were differences due to heterogeneity of samples which were not methodological. Growth in cell culture and differentiation were satisfactory. Simulation of treating the cells in a clinical environment show a general stability in viability of amniotic fluid cells at room temperature for 3 h minimum and when passed through a clinically approved delivery device. CONCLUSIONS:The data indicate human amniotic fluid processed in a clinical facility could be used therapeutically if proven to be safe.
PMID: 35985014
ISSN: 1619-3997
CID: 5300322

Pregnancy outcomes with differences in grain consumption: a randomized controlled trial

Yamada, Pamella; Paetow, Alexandra; Chan, Michael; Arslan, Alan; Landberg, Rikard; Young, Bruce K
OBJECTIVES/OBJECTIVE:Contemporary obstetrics has begun to appreciate the importance of diet in pregnancy, but guidelines are not based on robust data. The hypothesis that a whole grains diet improves pregnancy outcomes is tested in this study. We compared maternal and neonatal outcomes for a pregnancy diet containing 75% of total carbohydrates as refined grains with outcomes for a diet with 75% of total carbohydrates as whole grains. METHODS:This was a randomized interventional study in a clinic population over the last 4-7 months of normal pregnancy with extensive compliance measures. Besides obstetrical and neonatal outcomes, anthropometric measurements were done. In addition to food frequency questionnaires (FFQs), total plasma alkyl resorcinols, a unique quantitative measure of whole grains, were used as a measure of whole grain consumption. RESULTS:The data show effective compliance and no difference in outcomes between the diets with regard to maternal weight gain, birth weights, subcutaneous fat and glucose tolerance. CONCLUSIONS:Ensuring compliance to a proper pregnancy diet resulted in satisfactory weight gain and normal outcomes even when the proportion of whole grains consumed is only 25% of total carbohydrates. NCT03232762, Effects of Diet on Pregnancy Outcome and Child Obesity.
PMID: 34981703
ISSN: 1619-3997
CID: 5106972

A randomized controlled trial of the effects of whole grains versus refined grains diets on the microbiome in pregnancy

Sun, Haipeng; Yamada, Pamella; Paetow, Alexandra; Chan, Michael; Arslan, Alan; Landberg, Rikard; Dominguez-Bello, Maria Gloria; Young, Bruce K
Dietary whole grain consumption has been postulated to have metabolic benefits. The purpose of this study was to compare a pregnancy diet containing 75% of total carbohydrates as refined grains with a diet of 75% of total carbohydrates as whole grains for pregnancy outcomes and effects on the microbiome. Gestational weight gain, glucose tolerance and newborn outcomes were measured on 248 enrolled compliant women from whom a subset of 103 women consented to give 108 vaginal and 109 anal swabs. The data presented here are limited to the patients from whom the vaginal and anal swabs were obtained in order to study the microbiome. A microbiome-16SrRNA survey-was characterized in these samples. Samples and measurements were obtained at the first obstetrical visit, before beginning a prescribed diet (T1-baseline) and after 17-32 weeks on the prescribed diet (T3). Food frequency questionnaires and total plasma alkylresorcinols were used as a measure of whole grain consumption. There were no dietary differences in maternal weight gain, birth weight, or glucose tolerance test. Mothers consuming the whole grains diet showed a trend of gestational decrease in vaginal bacterial alpha diversity, with increasing Lactobacillus-dominance. No significant difference was observed for the anal microbiome. The results suggest that diet modulations of the vaginal microbiome during gestation may have important implications for maternal and neonatal health and in the intergenerational transfer of maternal microbiome. Trial registration: Identifier: NCT03232762.
PMID: 35525865
ISSN: 2045-2322
CID: 5213962

Multi-modal Framework for Fetal Heart Rate Estimation: Fusion of Low-SNR ECG and Inertial Sensors

Shokouhmand, Arash; Antoine, Clarel; Young, Bruce K; Tavassolian, Negar
This study presents a novel multi-modal framework for fetal heart rate extraction, which incorporates wearable seismo-cardiography (SCG), gyro-cardiography (GCG), and electrocardiography (ECG) readings from ten pregnant women. Firstly, a signal refinement method based on empirical mode decomposition (EMD) is proposed to extract the desired signal components associated with fetal heart rate (FHR). Afterwards, two techniques are developed to fuse the information from different modalities. The first method, named early fusion, is intended to combine the refined signals of different modalities through intra-modality fusion, intermodality fusion, and FHR estimation. The other fusion approach, i.e., late fusion, includes FHR estimation and intermodality FHR fusion. FHR values are estimated and compared with readings from a simultaneously-recorded cardiotocography (CTG) sensor. It is demonstrated that the best performance belongs to the late-fusion approach with 87.00% of positive percent agreement (PPA), 6.30% of absolute percent error (APE), and 10.55 beats-per-minute (BPM) of root-meansquare-error (RMSE).Clinical Relevance- The proposed framework allows for the continuous monitoring of the health status of the fetus in expectant women. The approach is accurate and cost-effective due to the use of advanced signal processing techniques and lowcost wearable sensors, respectively.
PMID: 34892753
ISSN: 2694-0604
CID: 5221072

Cesarean section one hundred years 1920-2020: the Good, the Bad and the Ugly

Antoine, Clarel; Young, Bruce K
In present-day obstetrics, cesarean delivery occurs in one in three women in the United States, and in up to four of five women in some regions of the world. The history of cesarean section extends well over four centuries. Up until the end of the nineteenth century, the operation was avoided because of its high mortality rate. In 1926, the Munro Kerr low transverse uterine incision was introduced and became the standard method for the next 50 years. Since the 1970's, newer surgical techniques gradually became the most commonly used method today because of intraoperative and postpartum benefits. Concurrently, despite attempts to encourage vaginal birth after previous cesareans, the cesarean delivery rate increased steadily from 5 to 30-32% over the last 10 years, with a parallel increase in costs as well as short- and long-term maternal, neonatal and childhood complications. Attempts to reduce the rate of cesarean deliveries have been largely unsuccessful because of the perceived safety of the operation, short-term postpartum benefits, the legal climate and maternal request in the absence of indications. In the United States, as the cesarean delivery rate has increased, maternal mortality and morbidity have also risen steadily over the last three decades, disproportionately impacting black women as compared to other races. Extensive data on the prenatal diagnosis and management of cesarean-related abnormal placentation have improved outcomes of affected women. Fewer data are available however for the improvement of outcomes of cesarean-related gynecological conditions. In this review, the authors address the challenges and opportunities to research, educate and change health effects associated with cesarean delivery for all women.
PMID: 32887190
ISSN: 1619-3997
CID: 4650182